DAB2IP and prostate carcinoma: In this study, similar to the results from prostate cancer, we also observed that DAB2IP-deficient renal cells acquired CSC potential based on CSC hallmarks [10] such as sphere-forming ability under ultralow-attachment growth condition (Figure 1A and 1B) and increased side population (SP) (Figure 1C).